Brief: Jasper Therapeutics Reports First Quarter 2023 Financial Results And Provides A Business Update
12/05/2023 21:10
Jasper Therapeutics Inc JSPR.O :
* JASPER THERAPEUTICS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
AND PROVIDES A BUSINESS UPDATE
* JASPER THERAPEUTICS INC - CASH AND CASH EQUIVALENTS
EXPECTED TO
BE SUFFICIENT TO FUND CO'S PLANNED OPERATING AND CAPITAL
EXPENDITURES THROUGH 2024
* JASPER THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.16
Source text for Eikon: ID:nGNX3dkYPR
Further company coverage: JSPR.O
Recent news on Jasper Therapeutics
See all newsBrief: Jasper Therapeutics Announces Commencement Of An Offer To Purchase Outstanding Warrants
Jasper Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Jasper Therapeutics Q2 loss per share beats estimates, raises $132 mln
Jasper Therapeutics, Inc. expected to post a loss of 35 cents a share - Earnings Preview
Jasper Therapeutics rises; co announces all-stock merger with Kira Pharma